RecruitingNCT06879964

Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study


Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment

120 participants

Start Date

Nov 17, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Post-operative radiotherapy (PORT) is currently considered as the second most important therapy to treat high-grade cutaneous squamous cell carcinoma. Nonetheless, only few studies evaluate its impact on recurrence rate and the major part of those ones do not include a proper control group of patients. Most recent guide lines from NCCN, Sidemast and British associations of dermatologists suggest clinicians to offer or consider PORT in selected patients but class nor level of evidence of those guide lines are provided. This project evaluates impact of post-operative radiotherapy on recurrence rate and overall survival by comparing two cohort of patients, the former who accepted PORT and the latter who, nonetheless its necessity, decided to not undergo it. The hypothesis which this project will answer concerns the effectiveness of post-operative radiotherapy in preventing local and regional recurrences. We expect a significant decrease of recurrence rate in patients who undergo this therapeutic option as compared to those with clinical indication but do not undergo PORT.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study examines whether radiation therapy given after surgery helps prevent high-grade skin cancer (cutaneous squamous cell carcinoma) from coming back. Researchers will look at real-world outcomes in patients who did or did not receive post-operative radiation to help inform future treatment guidelines. **You may be eligible if:** - You have been diagnosed with high-grade cutaneous squamous cell carcinoma (a serious type of skin cancer) - You are eligible for or have received post-operative radiation therapy - At least 24 months have passed since your treatment (so outcomes can be tracked) **You may NOT be eligible if:** - Your medical or pathology records are incomplete - You cannot be followed up reliably over time - You experienced a major event early in follow-up that would make data unreliable Note: This is an observational study — it tracks existing patients and does not assign new treatments. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione IRCCS Policlinico San Matteo, SC Dermatologia

Pavia, Pavia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06879964


Related Trials